Bank of New York Mellon Corp - ONCOMED PHARMACEUTICALS INC ownership

ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 1 filers reported holding ONCOMED PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ONCOMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$24,000
+33.3%
22,977
-2.4%
0.00%
Q4 2018$18,000
-64.0%
23,5380.0%0.00%
Q3 2018$50,000
-7.4%
23,538
-0.0%
0.00%
Q2 2018$54,000
-37.2%
23,539
-12.7%
0.00%
Q1 2018$86,000
-26.5%
26,953
-6.1%
0.00%
Q4 2017$117,000
+10.4%
28,707
+22.0%
0.00%
Q3 2017$106,000
+35.9%
23,538
-0.0%
0.00%
Q2 2017$78,000
-92.3%
23,539
-78.5%
0.00%
Q1 2017$1,007,000
+25.6%
109,273
+5.1%
0.00%
Q4 2016$802,000
-31.5%
103,968
+1.6%
0.00%
Q3 2016$1,170,000
+5.8%
102,347
+13.9%
0.00%
Q2 2016$1,106,000
+27.9%
89,819
+4.9%
0.00%
Q1 2016$865,000
-40.6%
85,593
+32.6%
0.00%
Q4 2015$1,456,000
+36.7%
64,556
+0.6%
0.00%
Q3 2015$1,065,000
-34.4%
64,183
-11.1%
0.00%
Q2 2015$1,624,000
+13.8%
72,162
+30.4%
0.00%
Q1 2015$1,427,000
+0.6%
55,360
-15.0%
0.00%
Q4 2014$1,418,000
+20.5%
65,111
+4.8%
0.00%
Q3 2014$1,177,000
-52.1%
62,141
-41.1%
0.00%
Q2 2014$2,456,000
+137.1%
105,438
+242.5%
0.00%
Q1 2014$1,036,000
+82.7%
30,782
+60.1%
0.00%
Q4 2013$567,00019,2290.00%
Other shareholders
ONCOMED PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
BVF INC/IL 4,042,989$8,571,0000.75%
NEXTHERA CAPITAL LP 634,715$1,346,0000.26%
Endurant Capital Management LP 219,114$465,0000.21%
Birchview Capital, LP 118,689$252,0000.16%
Perceptive Advisors 2,620,897$5,556,0000.15%
Alambic Investment Management, L.P. 53,972$114,0000.09%
Sofinnova Investments, Inc. 395,744$839,0000.08%
Kazazian Asset Management, LLC 31,475$67,0000.06%
Broadfin Capital, LLC 200,000$424,0000.06%
ESSEX INVESTMENT MANAGEMENT CO LLC 96,639$205,0000.02%
View complete list of ONCOMED PHARMACEUTICALS INC shareholders